SilviuItescuMD

Clinical & Laboratory Immunology

Physician

Are you Dr. Itescu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 30 invites waiting!
Read the latest clinical news, personalized to your specialty.

Office
177 Fort Washington Ave
7-453gn
New York, NY 10032
Phone+1 201-447-8717

Fax+1 201-251-3300

NYU Grossman School of MedicineFellowship, Rheumatology, 1987 - 1990
NYU Grossman School of MedicineResidency, Internal Medicine, 1984 - 1986
New York Medical College (Metropolitan)Internship, Internal Medicine, 1983 - 1984
Monash University Faculty of MedicineClass of 1981

PubMed

88 citations
Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.
Hirotsugu Hamamoto, Joseph H. Gorman, Liam P. Ryan, Robin Hinmon, Timothy P. Martens
The Annals of Thoracic Surgery. 2009-03-01
63 citations
Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration: A Report of the International Society for Cardiovascular Translat...
Nabil Dib, Philippe Menasché, Jozef Bartunek, Andreas M. Zeiher, Andre Terzic
JACC. Cardiovascular Interventions. 2010-03-01
35 citations
New strategies for early diagnosis of heart allograft rejection.
Sorina Tugulea, Rodica Ciubotariu, Adriana I. Colovai, Zhuoru Liu, Silviu Itescu
Transplantation. 1997-09-27

Longevity Investment Bulletin: Therini Bio, Calico, Alchemab and MoreApril 28th, 2023
DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology (JACC)February 27th, 2023
DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology (JACC)February 27th, 2023
Join now to see all